Mylan posts Street-beating Q4 earnings

Shares in Mylan (NSDQ:MYL) rose today after the EpiPen-maker met expectations on Wall Street with its 4th quarter results. The Canonsburg, Pa.-based company posted profits of $417.5 million, or $1.57 per share, on sales of $3.27 billion for the 3 months ended Dec. 31, for bottom-line growth of 114.5% on sales growth of 31.3% compared with the same period last year. Adjusted to exclude 1-time items, earnings per share were $1.57, ahead of consensus on The Street, where analysts were looking for sales of $2.37 billion. Get the full story at our sister site, Drug Delivery Business News. The post Mylan posts Street-beating Q4 earnings appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Drug-Device Combinations MassDevice Earnings Roundup Respiratory Wall Street Beat Mylan Source Type: news